3 ms·
There are times I'm glad I left health science/biology/medicine as a field and it's interesting to watch people slowly realize just how badly structured the ent
by dekhn 6y ago
There are times I'm glad I left health science/biology/medicine as a field and it's interesting to watch people slowly realize just how badly structured the entire human health field is organized (from academic research to research hospitals to profit hospitals to world health organizations) and how all the incentives are messed up.
The closer you get in biology to human health, the more ego, tribalism, and assholery you have to deal with. Something about "saving lives" really brings out the intelligent jerks and the sharks.
As a contrast, I enjoy working in computing so much more. The experiments people run are replicable, the code compiles, and people (in general) are far less egotistical and arrogant (still plenty of sharks, though).
I've watched enough major paradigm shifts in my own fields to know that embracing humility, admitting your own ignorance, and being open to new ideas is key to the furtherment of science.
- umvi 6y agoDumb question, but what's a "shark" in this context?
- dekhn 6y agoSharks are opportunists- for example people who wait for somebody else to do all the hard work, then come in, take over and get all the credit. It's not a really strong analogy but I've heard many people in biotech referring to sharks in that context.
- Avicebron 6y agoI will second this as I am currently working in the biotech field. The amount of short sighted thinking and opportunism from small start ups to the most massive CMO's in the world is staggering. My take is that the whole field is extremely underfunded and that breeds levels of competition and short term profit seeking, but that's probably a biased opinion. I'm sure if the field had the level of VC support that traditional software/computing gets we would be making huge strides with our humanity.
- DennisAleynikov 6y agothat's tragic. it seems the funnels of money that exist can't get anywhere meaningful without aggressive fundraising and being first to some buzzword
- dekhn 6y agoI don't know if the field is underfunded. What I'd say is that the area is very risky (few ideas really pan out), there are lots of powerful incumbents who want to retain the many-billion-$ revenue streams, and it's very costly to test. But I also see people wasting huge amount of money chasing ideas that really would be better handled with shotgunning (the tech VCs I used work with said "why would I want to invest $20M in a biotech that fails after 20 years, when i can invest $1M in 20 tech startups and one of them will make $1B in 2-3 years?"). It's not clear to me that investing more money helps, either. For example, the NIH doubled its budget during the Clinton era, leading to far higher numbers of grad students being trained than there were positions (prof, etc) in their fields. So there was a glut, super-high competition for a limited number of spaces, and many people dropped out of the race to be a prof and instead went to be ML/data science people at ads firms.